Wockhardt Ltd share price logo

Wockhardt Share Price (WOCKPHARMA)

Check the latest share price of Wockhardt, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹1776.20.47%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Wockhardt Stock Performance

Get live Wockhardt share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹1,705.1
    Day's Price Range
    ₹1,809.8
  • 52 Week's Low

    52 Week's High

    ₹552
    52-Week Price Range
    ₹1,847.8
1 Month Return+ 41.27 %
3 Month Return+ 37.71 %
1 Year Return+ 211.15 %
3 Year Return+ 646.15 %
5 Year Return+ 653.84 %
Previous Close₹1,784.50
Open₹1,708.00
Volume14.25L
Upper Circuit₹2,141.40
Lower Circuit₹1,427.60

Wockhardt Fundamentals & Key Indicators

Check Wockhardt market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹28,860.69 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

-576.69

Return on capital employed (ROCE)

0

Industry PE ratio

57.39

Beta (LTM)

1.65

P/B Ratio

5

Dividend Yield

0

PEG Ratio

-19.91

Quarterly Earnings Growth YOY

-74.58

EPS (TTM)

-30.65

Sector

Pharmaceuticals

Book Value

218.12

Technical Analysis

How to invest in Wockhardt?

Investing in Wockhardt is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Wockhardt or WOCKPHARMA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Wockhardt or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Wockhardt with just a few clicks!

Wockhardt Stock's Interest Amongst Investors

399.47%

Period Jun 14, 2025 to May 15, 2025. Change in 30 Days vs previous period

Investment in Wockhardt Ltd Shares on INDmoney has grown by 399.47% over the past 30 days, indicating increased transactional activity.

288%

Period Jun 14, 2025 to May 15, 2025. Change in 30 Days vs previous period

Search interest for Wockhardt Ltd Stock has increased by 288% in the last 30 days, reflecting an upward trend in search activity.

Wockhardt Valuation

Track how Wockhardt P/E has moved over time to understand its valuation trends.

Wockhardt in the last 5 years

  • Overview

  • Trends

Lowest (-594.51x)

June 11, 2025

Today (-576.69x)

June 13, 2025

Industry (57.39x)

June 13, 2025

Highest (12.70x)

May 26, 2021

LowHigh

Today’s Price to Earnings Ratio: -576.69x

Wockhardt Financial Results

Get the annual and quarterly financial summary of Wockhardt, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

700 (0%)739 (6%)809 (9%)721 (11%)743 (3%)
Net Income

(in ₹ Cr)

-177 (0%)-16 (91%)-16 (0%)20 (225%)-45 (325%)
Net Profit Margin-25.29% (0%)-2.17% (91%)-1.98% (9%)2.77% (240%)-6.06% (319%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

5096 (0%)6027 (18%)4978 (17%)5114 (3%)
Total Liabilities

(in ₹ Cr)

3490 (0%)3815 (9%)3225 (15%)3318 (3%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

222 (0%)-563 (354%)-93 (83%)71 (176%)188 (165%)

Indices Featuring Wockhardt Stock

Check stock indices that include Wockhardt.

Nifty Smallcap 250

₹17,210.40

-0.38 (-66.5%)

Nifty 500

₹22,906.20

-0.61 (-140.25%)

Nifty MidSmallcap 400

₹19,931.15

-0.37 (-73.35%)

BSE Small-Cap

₹53,370.29

-0.3 (-161.18%)

BSE Healthcare

₹43,995.31

0.08 (34.42%)

Wockhardt Earnings and Dividends

View detailed summary of the earnings and dividend history of Wockhardt.

  • Wockhardt Ltd Earnings Results

    Wockhardt Ltd’s net profit jumped 85.21% since last year same period to ₹-25Cr in the Q4 2024-2025. On a quarterly growth basis, Wockhardt Ltd has generated -278.57% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Wockhardt Ltd Dividends November,2016

    In the quarter ending September 2016, Wockhardt Ltd has declared dividend of ₹10 - translating a dividend yield of 0.56%.

    Read More about Dividends

Wockhardt Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Wockhardt.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
49.09%
0.00
Foreign Institutions
6.81%
0.00
Mutual Funds
7.56%
0.00
Retail Investors
33.5%
0.00
Others
3.05%
0.00

Wockhardt vs Peers

Compare market cap, revenue, PE, and other key metrics of Wockhardt with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA28,860.69130.77%0.77-4722,798
BUY38,428.87101.79%0.523001,051
BUY17,430.6117.42%0.57726,702
NA5,383.812.8%0.79-38875
BUY14,436.5943.15%0.682441,515

Wockhardt News & Key Events

Latest news and events in one place to help you make informed investing decisions in Wockhardt.

  • Wockhardt Shares Surge to 52-Week High - 11 Jun, 2025

    Wockhardt Ltd's shares jumped 17% to a 52-week high of ₹1,810.45, driven by strong investor interest and positive financial results, including a 67% YoY EBITDA growth.
  • Wockhardt Targets Growth in Antibiotics and Insulin Markets - 06 Jun, 2025

    Wockhardt is focusing on a $7 billion market for its antibiotic Zaynich, with USFDA filing expected soon. Additionally, the company plans to double insulin production capacity to meet rising demand.
  • Wockhardt Targets $7 Billion Market with Zaynich - 05 Jun, 2025

    Wockhardt has filed for regulatory approval of its novel antibiotic Zaynich, aiming for a launch in India and targeting a $7 billion market in the US and Europe. The company reported a narrowing net loss and increased revenue, indicating improved financial health.
  • Wockhardt Targets Revenue Growth and UK Market Expansion - 04 Jun, 2025

    Wockhardt's MD emphasizes the recommendation of India-made drugs in the UK, while the company aims to increase revenue to Rs 5,000 crore in three years, driven by new high-margin products.
  • Wockhardt Narrows Loss and Increases Revenue in Q4 - 29 May, 2025

    Wockhardt Ltd reported a narrowed net loss of Rs 45 crore for Q4 FY25, significantly improved from Rs 177 crore last year. Revenue increased by 6% to Rs 743 crore. The company also announced the re-appointment of Akhilesh Krishna Gupta as Independent Director, pending shareholder approval. These developments reflect Wockhardt's recovery efforts and operational improvements, boosting investor confidence.

Insights on Wockhardt Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 729.0 Cr → 758.0 Cr (in ₹), with an average increase of 3.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, WOCKPHARMA stock has moved up by 17.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 6.54% to 6.81% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.13% to 7.56% in Mar 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 49.09% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 34.53% to 33.50% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 14.0 Cr → -25.0 Cr (in ₹), with an average decrease of 278.6% per quarter

About Wockhardt

Wockhardt Ltd. is an Indian pharmaceutical and biotechnology company that is listed on the Indian stock exchange. Founded in the early 1960's, the company has grown to become a recognized leader in the development of quality products and providing healthcare solutions across the world. Wockhardt has a global presence, with research and development facilities in the United States, Europe and India. With an extensive portfolio of products that includes medicines, vaccines, biopharmaceuticals, and health supplements, Wockhardt is committed to providing access to safe and innovative solutions to meet the unique needs of customers and communities. Wockhardt is a growing company with a strong commitment to providing reliable, quality products and services to its customers across the globe.

Revenue: ₹743.00Cr as on March 2025 (Q4 FY25)
Net Profit: ₹-45.00Cr as on March 2025 (Q4 FY25)
Listing date: 23 Feb, 2000
Chairperson Name: H F Khorakiwala
OrganisationWockhardt Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOH F Khorakiwala
E-voting on sharesClick here to vote

Mutual Funds that own Wockhardt

Check out the Mutual Funds with significant holdings in Wockhardt.

FAQs

What is Wockhardt share price today?

Wockhardt share price today stands at ₹1776.2, Open: ₹1708, Previous Close: ₹1784.5, High: ₹1809.8, Low: ₹1705.1, 52 Week High: ₹1847.8, 52 Week Low: ₹552.

What is today's traded volume of Wockhardt?

Today's traded volume of Wockhardt is 14.25L. Which means that 14.25L shares of Wockhardt were bought and sold on the stock market during today's trading session.

What is Wockhardt's market cap today?

Today's market capitalisation of Wockhardt is ₹28,860.69 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Wockhardt?

Wockhardt’s 52 week high is ₹1847.8 and 52 week low is ₹552. The current share price of Wockhardt is ₹1776.2, which is -3.87% down from its 52 week high and 221.78% up from its 52 week low.